Respiratory Mechanics Assessment During Assisted Mechanical Ventilation

NCT ID: NCT05203536

Last Updated: 2025-05-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

298 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-09-01

Study Completion Date

2023-06-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To verify the association between respiratory system mechanical properties (ΔP, ΔPL,dyn, Pmus, Pplat and CRS and CL,dyn) assessed during assisted modes of ventilation (as average over the first three days since enrollment) and ICU mortality.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Hypoxemic Respiratory Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Acute Hypoxaemic Respiratory Failure (defined as respiratory failure requiring invasive mechanical ventilation with a PaO2/FiO2\< 300 mmHg) during the course of ICU stay (including ARDS).
* Invasive mechanical ventilation in one of these modes: Pressure A/C, PRVC, SIMV PC, PSV, NAVA, PAV+, BiPAP
* Presence of spontaneous breathing activity (ventilator triggering), since 6 hours and no longer than 48 hours
* Patient for full active management at this point.

Exclusion Criteria

* Age \<18 years old
* Pregnancy
* Active air leaks
* Moribund state
* High ICP
* Patient has passed a spontaneous breathing trial (if performed for clinical indication)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Milano Bicocca

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Toronto General Hospital

Toronto, Toronto, Canada

Site Status

University Medical Centre Schleswig-Holstein

Kiel, Kiel, Germany

Site Status

University Hospital Galway

Galway, Galway, Ireland

Site Status

Ospedale Sant'Anna

Ferrara, Ferrara, Italy

Site Status

Policlinico di Milano Ospedale Maggiore

Milan, Milano, Italy

Site Status

ASST-Monza, Ospedale San Gerardo

Monza, Monza, Italy

Site Status

Vall d'Hebron University Hospital

Barcelona, Barcelona, Spain

Site Status

Hospital Clinic de Barcelona

Barcelona, Barcelona, Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada Germany Ireland Italy Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

3552

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.